Environmentally friendly non-polar solvents are solvents that have low toxicity, low volatility, and are biodegradable. They are typically derived from renewable resources and do not contribute to ozone depletion or global warming. Examples of environmentally friendly non-polar solvents include limonene, terpenes, and certain types of vegetable oils. These solvents are being increasingly used as alternatives to traditional petroleum-based solvents in various industries to reduce environmental impact. **

It is non-competitive inhibition. This is because the inhibitor binds to an allosteric site on the enzyme, which is different from the active site where the substrate binds. This type of inhibition does not compete with the substrate for binding to the enzyme, hence the name non-competitive inhibition. **

Non-competitive inhibition is a type of enzyme inhibition where the inhibitor binds to a site on the enzyme that is not the active site. This binding causes a conformational change in the enzyme, making it less effective at catalyzing the reaction. Non-competitive inhibitors do not compete with the substrate for binding to the enzyme. Instead, they can bind to the enzyme-substrate complex or to a separate allosteric site on the enzyme. **

Competitive inhibition occurs when a molecule competes with the substrate for the active site of the enzyme, thus reducing the enzyme's ability to bind with the substrate. Non-competitive inhibition, on the other hand, occurs when a molecule binds to a site on the enzyme other than the active site, causing a conformational change in the enzyme that reduces its activity. In competitive inhibition, increasing the substrate concentration can overcome the inhibition, while in non-competitive inhibition, increasing the substrate concentration does not alleviate the inhibition. **

Non-competitive inhibition is a type of enzyme inhibition that is reversible. In non-competitive inhibition, the inhibitor binds to the enzyme at a site other than the active site, causing a conformational change in the enzyme that reduces its activity. This type of inhibition can be overcome by increasing the substrate concentration, as it does not involve permanent alteration of the enzyme. **

An example of non-competitive inhibition is the binding of an allosteric inhibitor to an enzyme at a site other than the active site. This binding causes a conformational change in the enzyme, which reduces its activity and prevents the substrate from binding to the active site. This type of inhibition does not compete with the substrate for binding to the active site, hence the term "non-competitive." An example of this is the binding of ATP to the enzyme phosphofructokinase in glycolysis, which inhibits its activity. **

Sure! In competitive inhibition, a molecule similar in structure to the substrate competes with the substrate for the active site of the enzyme. This prevents the substrate from binding to the enzyme and carrying out its normal function. An example of this is the drug statins, which competitively inhibit the enzyme HMG-CoA reductase, involved in cholesterol synthesis. In non-competitive inhibition, a molecule binds to the enzyme at a location other than the active site, causing a conformational change in the enzyme that reduces its activity. An example of this is the poison cyanide, which non-competitively inhibits the enzyme cytochrome c oxidase in the electron transport chain, disrupting cellular respiration. **

Allosteric inhibition and non-competitive inhibition are not the same, although they are related. Non-competitive inhibition refers to the binding of an inhibitor to a site on the enzyme that is not the active site, thereby preventing the substrate from binding to the active site. Allosteric inhibition, on the other hand, occurs when an inhibitor binds to a site on the enzyme that is distinct from the active site, causing a conformational change in the enzyme that reduces its activity. While both types of inhibition involve the binding of an inhibitor to a site other than the active site, allosteric inhibition specifically involves a change in the enzyme's shape and activity. **